InvestorsHub Logo
Followers 19
Posts 1896
Boards Moderated 0
Alias Born 02/10/2014

Re: Waitforit53 post# 10841

Wednesday, 04/09/2014 1:29:32 PM

Wednesday, April 09, 2014 1:29:32 PM

Post# of 48316
The other piece of the puzzle with timing would be the potentially increased data from ONCS' 21 patient expansion trial where it upped the frequency of treatments. That would be one heck of Phase 2B trial if the trial was based upon an already FDA approved anti-PD1 drug combined with Immunopulse (with data that is even better with increased frequency of treatments). Talk about a potential home run trial.